Inventor · disambiguated record
Mark Cragg
Also filed as: CRAGG MARK · CRAGG MARK STEVEN
7 granted patents·4 pending applications·6 citations·filing 2011–2023
75Inventor score
Top patents by PatentIndex Score
11 records- 0185US11623005B2Combined use of FcγRIIb (CD32B) and CD20 specific antibodiesUNIV SOUTHAMPTON·Filed 2019·Granted Apr 11, 2023·3 cites·5 claims
- 0273US11001638B2Immunomodulatory antibodiesCANCER RESEARCH TECH LTD·Filed 2016·Granted May 11, 2021·1 cites·4 claims
- 0370US2021346498A1Combined use of fc gamma riib (cd32b) and cd20 specific antibodiesUNIV SOUTHAMPTON·Filed 2021·Application pending·0 cites
- 0465US10525129B2Combined use of Fc gamma RIIb (CD32B) and CD20-specific antibodiesCRAGG MARK·Filed 2011·Granted Jan 7, 2020·2 cites·32 claims
- 0564US11780929B2Immunomodulatory antibodiesCANCER RESEARCH TECH LTD·Filed 2021·Granted Oct 10, 2023·0 cites·3 claims
- 0658US2025326849A1COMBINATION OF A FcyRIIB- AND A TUMOR ANTIBODY FOR USE IN THE TREATMENT OF AN FcyRIIB-NEGATIVE CANCERUNIV SOUTHAMPTON·Filed 2023·Application pending·0 cites
- 0753US2024092912A1Novel combinations of antibodies and uses thereofBIOINVENT INT AB·Filed 2022·Application pending·0 cites
- 0846US12344673B2Medicaments, uses and methodsBIOINVENT INT AB·Filed 2015·Granted Jul 1, 2025·0 cites·14 claims
- 0946US2022259309A1Antibody combinations for treatment of cancer in specific patientsBIOINVENT INT AB·Filed 2020·Application pending·0 cites
- 1044US12371498B2Combination and use of antibodiesBIOINVENT INT AB·Filed 2019·Granted Jul 29, 2025·0 cites·16 claims
- 1141US12325754B2Cancer and B-cell related disease therapyUNIV SOUTHAMPTON·Filed 2017·Granted Jun 10, 2025·0 cites·16 claims
Join the waitlist — get patent alerts
Get an alert when Mark Cragg files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →